Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Terns Pharmaceuticals Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Plus Therapeutics (PSTV) and Terns Pharmaceuticals (TERN). Plus T...

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Terns Pharmaceuticals (TERN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Terns Pharmaceuticals (TERN), Sangamo Therapeutics (SGMO) and Gal...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Terns Pharmaceuticals (TERN), Sangamo Therapeutics (SGMO) and Galectin Therapeutics (GALT)

Analysts fell to the sidelines weighing in on Aveanna Healthcare Holdings (AVAH) and Terns Pharmaceuticals (TERN) with neutral ratings, indicating ...

Analysts Are Neutral on Top Healthcare Stocks: Aveanna Healthcare Holdings (AVAH), Terns Pharmaceuticals (TERN)

Investors will find the hottest stock market stories for Wednesday in our wrap-up.


Morning News Wrap-Up 3/25/26: Today’s Biggest Stock Market Stories!

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fractyl Health, Inc. (GUTS) and Terns Pharmaceutic...

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS) and Terns Pharmaceuticals (TERN)

U.S.-based Merck & Co. ($MRK) is reportedly nearing a $6 billion all-cash deal to acquire biotech company Terns Pharmaceuticals ($TERN) as part of ...

Merck Chases $6B Terns Pharma Deal Ahead of Keytruda Patent Expiry — TERN and MRK Stocks Rise

Terns Pharmaceuticals ( ($TERN) ) has shared an update. On March 24, 2026, Terns Pharmaceuticals agreed to be acquired by Merck in an all-cash deal...

Market Cap	$1.62B	P/E Ratio	N/A
52W High	$53.19	52W Low	$1.87
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	20.3%	52W Position	99.0%
Overall Score	65	Value Score	50
Quality Score	--	Technical Score	81

EPS Current Est	$-1.07	EPS Next Est	$-1.21
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	TERN	$52.66	+0.07%	12.08M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	TERN	$52.66	+0.1%	12.08M
3
4
5
6

TERN

TERN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Terns Pharmaceuticals Inc. Data in Excel

Get Terns Pharmaceuticals Inc. Data in Excel